Sun Pharma Inks Global Licensing Deal With LIB Therapeutics For PCSK9 Inhibitor[1]
Sun Pharma inks global licensing pact with LIB Therapeutics for cholesterol drug Lerodalcibep[2]
What remains disputed or unverified
No disputed central claims are recorded for this story.
What is confirmed
Sun Pharma Inks Global Licensing Deal With LIB Therapeutics For PCSK9 Inhibitor[1]
Sun Pharma inks global licensing pact with LIB Therapeutics for cholesterol drug Lerodalcibep[2]
Sources and ownership
This brief cites 2 reports from 2 sources (Free Press Journal, Business Line - Home) under 2 separate ownership groups. Sources under separate ownership are less likely to repeat the same reporting error. Cited Current publishes a template brief only when an event is corroborated by at least 2 independently owned sources or by an official or wire report.[1][2]
First detected September 28, 2026 at 04:59 UTC; the earliest cited report was published September 28, 2026 at 04:47 UTC. All times are UTC.[1][2]
No published comments yet. Be the first to add useful context.